SCHEMBL2556719

SCHEMBL2556719

ClC1(c2ccc3c(c2)CNCc2nncn2-3)CC=C(c2cccc3ccccc23)CC1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.31
OPRK1 P41145 1/20 0.30
PDE4D Q08499 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2551927 0.88 OPRK1 (0.31) OPRK1PDE4D
Hydrochloric Acid SCHEMBL2559362 0.88 OPRK1 (0.37) OPRK1PDE4D
SCHEMBL2563159 0.87 OPRK1 (0.37) OPRK1PDE4D
Hydrochloric Acid SCHEMBL2561790 0.86 CYP11B2 (0.32)
Hydrochloric Acid SCHEMBL2558245 0.82 CYP11B2 (0.32)
Hydrochloric Acid SCHEMBL2558784 0.79 HSD11B1 (0.37)
Hydrochloric Acid SCHEMBL2556061 0.79 CCNT1 (0.38)
SCHEMBL2559627 0.79 CCNT1 (0.38)
SCHEMBL2548604 0.75
Hydrochloric Acid SCHEMBL2551680 0.74 OPRK1 (0.34) OPRK1PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558467-A1 ARYL - /HETEROARYL - CYCLOHEXENYL - TETRAAZABENZO [E]AZULENES AS VASOPRESSIN ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-20 EP claimed
WO-2011128265-A1 ARYL - /HETEROARYL - CYCLOHEXENYL - TETRAAZABENZO [E] AZULENES AS VASOPRESSIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO claimed
EP-2558467-A1 ARYL - /HETEROARYL - CYCLOHEXENYL - TETRAAZABENZO [E]AZULENES AS VASOPRESSIN ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
WO-2011128265-A1 ARYL - /HETEROARYL - CYCLOHEXENYL - TETRAAZABENZO [E] AZULENES AS VASOPRESSIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed